OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
Mohamed H. Yousef, Hassan A. N. El‐Fawal, Anwar Abdelnaser
BioMed Research International (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 15
Mohamed H. Yousef, Hassan A. N. El‐Fawal, Anwar Abdelnaser
BioMed Research International (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 15
Showing 15 citing articles:
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma
Reham Hammad, Mona A. Eldosoky, Asmaa A. Elmadbouly, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15349-15364
Open Access | Times Cited: 30
Reham Hammad, Mona A. Eldosoky, Asmaa A. Elmadbouly, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15349-15364
Open Access | Times Cited: 30
CDK regulators—Cell cycle progression or apoptosis—Scenarios in normal cells and cancerous cells
Nilmani, Maria D'costa, Anusha Bothe, et al.
Advances in protein chemistry and structural biology (2023), pp. 125-177
Closed Access | Times Cited: 29
Nilmani, Maria D'costa, Anusha Bothe, et al.
Advances in protein chemistry and structural biology (2023), pp. 125-177
Closed Access | Times Cited: 29
Epigenetic Modulators as Therapeutic Agents in Cancer
Eshaan Patnaik, Chikezie O. Madu, Yi Lü
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14964-14964
Open Access | Times Cited: 24
Eshaan Patnaik, Chikezie O. Madu, Yi Lü
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14964-14964
Open Access | Times Cited: 24
Reviewing cancer’s biology: an eclectic approach
Ibrahim KARIDIO DIORI, Şenay Hamarat Şanlıer
Journal of the Egyptian National Cancer Institute (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 36
Ibrahim KARIDIO DIORI, Şenay Hamarat Şanlıer
Journal of the Egyptian National Cancer Institute (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 36
Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma
Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12541-12541
Open Access | Times Cited: 26
Reham Hammad, Reda Badr Aglan, Shaymaa A. Mohammed, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12541-12541
Open Access | Times Cited: 26
Advanced Nanotheranostic Approaches for Hepatocellular Carcinoma Management
Sachin Kothawade, Vijaya Padwal, Pranav Lodha, et al.
Journal of Medicine Surgery and Public Health (2025), pp. 100188-100188
Open Access
Sachin Kothawade, Vijaya Padwal, Pranav Lodha, et al.
Journal of Medicine Surgery and Public Health (2025), pp. 100188-100188
Open Access
Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials
Qichuan Deng, Yü Huang, Jing Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117343-117343
Open Access | Times Cited: 3
Qichuan Deng, Yü Huang, Jing Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117343-117343
Open Access | Times Cited: 3
Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma
Lihua Qu, Qian Fang, Tong Yin, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2449-2467
Open Access | Times Cited: 13
Lihua Qu, Qian Fang, Tong Yin, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2449-2467
Open Access | Times Cited: 13
5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway
Federica Tonon, Maja Čemažar, Urška Kamenšek, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1630-1630
Open Access | Times Cited: 13
Federica Tonon, Maja Čemažar, Urška Kamenšek, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1630-1630
Open Access | Times Cited: 13
Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells
Mina Baek, Minjae Kim, Hae In Choi, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301663-e0301663
Open Access | Times Cited: 2
Mina Baek, Minjae Kim, Hae In Choi, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301663-e0301663
Open Access | Times Cited: 2
Reactive Oxygen Species and Long Non-Coding RNAs, an Unexpected Crossroad in Cancer Cells
Teodor Paul Kacso, Renata Zahu, Alexandru Tirpe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10133-10133
Open Access | Times Cited: 10
Teodor Paul Kacso, Renata Zahu, Alexandru Tirpe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10133-10133
Open Access | Times Cited: 10
Epigenetic drug discovery: Recent advances through structure-activity relationships and phenotypic profiling studies
Amit Pant, Christopher J. Pelham, Gopal P. Jadhav
Elsevier eBooks (2023), pp. 615-630
Closed Access | Times Cited: 1
Amit Pant, Christopher J. Pelham, Gopal P. Jadhav
Elsevier eBooks (2023), pp. 615-630
Closed Access | Times Cited: 1
Epigenetic biomarkers in diagnosis, prognosis, and treatment of hepatocellular carcinoma
Eka Kvaratskhelia, Ketevani Kankava, Sandro Surmava, et al.
Elsevier eBooks (2022), pp. 415-433
Closed Access
Eka Kvaratskhelia, Ketevani Kankava, Sandro Surmava, et al.
Elsevier eBooks (2022), pp. 415-433
Closed Access
Research on Mechanism of Doxorubicin Carried with Mesoporous Silica Nanoparticles Mesoporous Silica Nanoparticles in Regulating the Activity of Liver Tumor Cells Through Regulating the Activity of Hippo-Yes-Associated Protein Signal Pathway
An Wang, Jianshuai Jiang
Science of Advanced Materials (2022) Vol. 14, Iss. 3, pp. 521-527
Closed Access
An Wang, Jianshuai Jiang
Science of Advanced Materials (2022) Vol. 14, Iss. 3, pp. 521-527
Closed Access
الإنتاج الفکري المصري في مجال سرطان الکبد: دراسة ببليومترية تحليلية باستخدام برنامجي Biblioshiny وVOSviewer
اسماعيل رجب عثمان
Al-Mağallah Al-ʿilmiyyaẗ Lil-Maktabāt wa Al-Waṯā'iq wa Al-Ma'lūmāt (2022) Vol. 5, Iss. 13.1, pp. 63-103
Open Access
اسماعيل رجب عثمان
Al-Mağallah Al-ʿilmiyyaẗ Lil-Maktabāt wa Al-Waṯā'iq wa Al-Ma'lūmāt (2022) Vol. 5, Iss. 13.1, pp. 63-103
Open Access
